Investigation
Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Menu
Investigation
02/02/2021
Initial Lawsuit
02/02/2021
Lawsuit Progression
04/05/2021
Plaintiff brings this securities class action on behalf of persons or entities who purchased or otherwise acquired publicly traded Tyson securities between March 13, 2020 and December 15, 2020, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(1) Tyson knew, or should have known, that the highly contagious coronavirus was spreading throughout the globe;
(2) Tyson did not in fact have sufficient safety protocols to protect its employees in its facilities;
(3) as a result, Tyson employees contracted and spread the coronavirus within the facilities;
(4) as a result of the foregoing, Tyson would face negative impact to its production, including complete shutdowns of certain facilities;
(5) due to the failure to protect its employees, Tyson would suffer financial harm related to its lowered production;
(6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.